10x Genomics, Inc. TXG Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s change in deferred revenue?
- 10x Genomics, Inc. (TXG) reported change in deferred revenue of $77K in Q1 2026.
- How has 10x Genomics, Inc.'s change in deferred revenue changed year-over-year?
- 10x Genomics, Inc.'s change in deferred revenue decreased by 77.8% year-over-year, from $347K to $77K.
- What is the long-term trend for 10x Genomics, Inc.'s change in deferred revenue?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s change in deferred revenue has grown at a -16.5% compound annual growth rate (CAGR), from $1.54M to $746K.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.